scispace - formally typeset
U

Ulla-Stina Salminen

Researcher at University of Helsinki

Publications -  58
Citations -  969

Ulla-Stina Salminen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Transplantation & Bronchiolitis obliterans. The author has an hindex of 18, co-authored 57 publications receiving 891 citations. Previous affiliations of Ulla-Stina Salminen include Helsinki University Central Hospital.

Papers
More filters
Journal ArticleDOI

Biodegradation of the copolymeric polylactide stent. Long-term follow-up in a rabbit aorta model.

TL;DR: It is concluded that the PLA96 stent degraded with minimal tissue response within 24 months, and may be a promising stent core material for small vessels in the future, although further investigation is needed to establish its final biocompatibility.
Journal ArticleDOI

Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting.

TL;DR: Reperfusion injury was observed in one fourth of the deaths in association with MI and occurred more often in patients with preoperative NYHA III symptoms and in those in whom endarterectomy was carried out, indicating the lethal nature of this complication.
Journal ArticleDOI

Novel Zero-Heat-Flux Deep Body Temperature Measurement in Lower Extremity Vascular and Cardiac Surgery

TL;DR: According to this preliminary study, the deep body temperature measured using the zero-heat-flux system was in good agreement with standard core temperatures during lower extremity vascular and cardiac surgery, however, agreement was questionable during hypothermia below 32°C.
Journal ArticleDOI

Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG).

TL;DR: The post-mortem angiographic technique, yielding a permanent rubber- cast model of the graft and anastomosis site, improves the accuracy of diagnostics of postoperative CABG complications and eases postoperative autopsy dissection, which can now be directed to confirm suspected complications.
Journal ArticleDOI

Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation

TL;DR: The median survival time was slightly increased from 8 to 12 months for those patients who completed the protocol treatments, but progressive disease was the invariable outcome, and data relating to therapeutic responses and treatment programs in malignant mesothelioma should be better correlated internationally.